USSTOCK.TODAY
Market Closed
Log in Sign up

AstraZeneca Q3 Core EPS Beats Consensus

Earnings Whispers · ·by G4L

AZN Astrazeneca plc
$186.76 -1.39%
View chart & analysis →
  1. 1AstraZeneca exceeded consensus in its third-quarter results.
  2. 2AstraZeneca's Q3 core earnings per share (EPS) of $2.79 recorded 7.3%, exceeding the Q3 consensus of $2.60.
  3. 3AstraZeneca management reaffirmed its annual guidance.

So what's the key point?

AstraZeneca earned more profit in the third quarter than experts expected. The company also maintained its targets for this year.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Eli Lilly widens market cap gap with Novo Nordisk in obesity treatment competition The Motley Fool +7 · yesterdayRhythm Pharmaceuticals shares surge 28% on AstraZeneca's $10 billion acquisition proposal WSJ +2 · 6d agoAstraZeneca Cost Cutting, Alnylam Shares Plunge, Regeneron Earnings Beat BioPharma Dive · Nov 2
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news